Related Experiment Video
Updated: Mar 13, 2026
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.8K
Chemokine-chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment
Yang Zhao1,2, Xueqian Wang3,4, Tong Lei1,2
1State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Chinese Medical Journal
|March 12, 2026
Summary
Chemokines regulate immune cells in the tumor microenvironment (TME). Targeting chemokine signaling offers a promising strategy for cancer immunotherapy by modulating immune responses against tumors.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Chemokines are crucial for immune cell trafficking within the tumor microenvironment (TME).
- Altered chemokine gradients impact immune cell function, tumor growth, metastasis, and angiogenesis.
- Chemokine dysregulation is linked to cancer progression and patient outcomes.
Purpose of the Study:
- To review chemokine expression in various cancers.
- To examine chemokine receptor interactions with immune cells.
- To summarize therapeutic strategies targeting chemokine signaling in cancer immunotherapy.
Main Methods:
- Literature review of chemokine expression profiles in diverse tumor types.
- Analysis of chemokine receptor-mediated immune cell interactions.
- Synthesis of current therapeutic approaches targeting chemokine pathways.
Main Results:
- Chemokines shape the TME, dictating either anti-tumor or pro-tumor immune responses.
- Targeting the chemokine receptor axis is a key strategy in cancer immunotherapy.
- Chemokine signaling modulation can be used alone or in combination therapies.
Conclusions:
- Understanding chemokine roles in the TME is vital for cancer treatment.
- Therapeutic targeting of chemokines holds significant potential for improving cancer immunotherapy outcomes.
- Further research into chemokine signaling pathways can lead to novel cancer therapies.
Related Concept Videos
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:17The Tumor Microenvironment
3.0K
3.0K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
01:15Receptor Downregulation in MVBs
2.9K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.9K